FARA - Press Releases

What is Friedreich's Ataxia?

FARA Mission / Organization

FARA Leadership

Scientific Advisory Board

About FARA

Press Releases

2011

EPI-A0001 Improves Neurological Outcome Endpoint in 28-Day Phase 2A Double-Blind Placebo-Controlled Clinical Trial in Friedreich’s Ataxia
June 11, 2011

FDA Grants Orphan Drug Designation to EPI-743 and Allows Expanded Access in Mitochondrial Diseases Including Friedreich’s Ataxia
June 8, 2011

4th International Friedreich’s Ataxia Scientific Conference to Convene May 5th-7th 2011
May 1, 2011

Intellect Neurosciences Files Orphan Drug Application in the United States for its Clinical Candidate OX1 for the Treatment of Friedreich’s Ataxia
Apr 12, 2011

The Friedreich’s Ataxia Research Alliance Joins Millions Around World To Observe Rare Disease Day
Feb 19, 2011

Years

2012
2011
2010
2009
2008
2007
2006
2005
2004